Prof. Benoit Van den Eynde
The Van den Eynde group studies immune responses to cancer, with the long-term goal of harnessing the immune system to fight cancer.
Research in our group has two main themes. Firstly, we focus on the processing of tumour antigens and study the role of the proteasome and other proteases in the production of tumour antigenic peptides. Secondly, we investigate innovative preclinical models for cancer immunotherapy to decipher the mechanisms whereby tumours resist immune rejection. The long-term objectives are to better understand the interaction of tumours with the immune system and to devise strategies to improve the efficacy of cancer immunotherapy.